PRZOOM - /newswire/ -
Piscataway, NJ, United States, 2009/05/21 - GenScript Corporation will participate in the BIT Life Sciences’1st Annual International Congress of Antibodies (ICA), which is scheduled to be held in Beijing during May 22–24. 1548:HK
Internationally recognized biology contract research organization GenScript Corporation will participate in the BIT Life Sciences’1st Annual International Congress of Antibodies (ICA), which is scheduled to be held in Beijing during May 22–24, 2009
The congress will provide a platform for participants to learn the latest technologies and developments for antibodies and their R&Ds, to share thoughts and gain insight on the market trend, and to build partnerships with the industry decision makers and their enterprises.
During the conference that will be held in Beijing Continental Grand Hotel, Dr. Frank Zhang, GenScript’s CEO, will deliver a keynote presentation on how can CRO services benefit antibody drug discovery during 11:05–11:35 am. on May 22. He will also speak at the reception banquet. Dr. Guangli Wang, Director of GenScript’s Bio-process Department, will give a presentation on transient gene expression for fast monoclonal antibody production in session 4-1 during 5:55–16:20 pm. on May 22.
GenScript’s exhibition booth (#23), will be exhibited from 9:00 am.–18:00 pm. during May 22–24, 2009.
About GenScript Corporation
GenScript (genscript.com) is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.